8 Feb 2021 08:54
4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug
4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
DDDD.L Share News (DDDD)
DDDD Share
Price
DDDD Share
News
DDDD Share
Chat
DDDD Share
Trades
DDDD
Live RNS
DDDD Share
Charts
DDDD Broker
Ratings
DDDD Directors
Deals
DDDD Financial
Diary
DDDD
Fundamentals
DDDD Short
Positions
DDDD
Media
DDDD.L Information
- There is currently no data for DDDD
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.4D Pharma begins Thetanix phase 1 clinical trial
Mon, 22nd Aug 2016 11:57
(ShareCast News) - Pharmaceutical company 4D pharma has begun dosing in a phase 1 clinical trial with Thetanix for the treatment of Paediatric Crohn's disease (PCD).PCD is a rare chronic inflammatory bowel disease that is caused by the malfunction of the immune system leading to inflammation, or swelling, across the lining of the digestive tract.
More News
3 Feb 2021 11:19
4D Pharma makes progress with MRx0518 development programme
(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced progress on activities in its development programme for its lead immuno-oncology single strain 'live biotherapeutic' candidate MRx0518 on Wednesday.
Read more3 Feb 2021 10:50
SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward
SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward
Read more3 Feb 2021 09:01
4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress
4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress
Read more18 Dec 2020 10:13
4D Pharma Joins Landmark Study For Parkinson's Treatment Development
4D Pharma Joins Landmark Study For Parkinson's Treatment Development
Read more26 Nov 2020 10:53
4D Pharma Files US Registration Statement For ADR Programme
4D Pharma Files US Registration Statement For ADR Programme
Read more9 Nov 2020 17:28
IN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials
IN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials
Read more22 Oct 2020 15:42
IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition
IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition
Read more22 Oct 2020 11:06
UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans
UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans
Read more7 Oct 2020 11:25
4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial
4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial
Read more30 Sep 2020 12:04
IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase
IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase
Read more23 Sep 2020 19:22
UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board
UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board
Read more26 Aug 2020 10:40
UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook
UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook
Read more26 Aug 2020 09:41
4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"
4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"
Read more13 Jul 2020 18:25
UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech
UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech
Read more